Oral analgesic for musculoskeletal injuries in children: A systematic review and network meta‐analysis
Academic Emergency Medicine · 2024
DOI: 10.1111/acem.14803 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Academic Emergency Medicine, 2024. Verfasst von Shu Utsumi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Analgesics, Musculoskeletal System, Pain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Pain in pediatric musculoskeletal (MSK) injuries can lead to increased anxiety, fear, and avoidance of medical care, making analgesic management critical. Therefore, we evaluated analgesic efficacy and adverse effects to select the optimal analgesic agent in pediatric patients with MSK injuries.
Methods
Four databases were searched from inception to March 2023 for peer‐reviewed, open randomized controlled trials (RCTs). Inclusion criteria were: (1) trials with RCT design, (2) children aged 1 month–18 years with MSK injury, (3) outpatient setting, (4) interventions and control, (5) primary outcome of pain score at 60 and 120 min and secondary outcome of adverse effects, and (6) full‐text and peer‐reviewed articles. Two reviewers screened, extracted data, and assessed the risk of bias. A frequentist random‐effects network meta‐analysis (NMA) was performed. Certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation working group approach.
Results
We included eight trials comprising 1645 children. Ibuprofen was significantly associated with pain reduction at 120 min, compared with acetaminophen (SMD 0.31 [95% CI 0.11–0.51]; moderate certainty) and opioids (SMD 0.34 [95% CI 0.20–0.48]; moderate certainty). Compared with opioids alone, ibuprofen–opioid combination was significantly associated with pain reduction at 120 min (SMD 0.19 [95% CI 0.03–0.35]). No significant differences were found in pain interventions at 60 min. Ibuprofen had statistically fewer adverse events than opioids (RR, 0.54 [95% CI 0.33–0.90]; moderate certainty) and ibuprofen with opioids (RR 0.47 [95% CI 0.25–0.89]; moderate certainty). In terms of limitations, the eight RCTs included had relatively small sample sizes; only two were high‐quality RCTs.
Conclusions
Our NMA found ibuprofen to be the most effective and least adverse analgesic in pediatric patients with MSK injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
- Department of Emergency and Transport Medicine, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Shu Utsumi, Shunsuke Amagasa
Zitieren
APA
Utsumi, S., Amagasa, S., Moriwaki, T., & Uematsu, S. (2024). Oral analgesic for musculoskeletal injuries in children: A systematic review and network meta‐analysis. Academic Emergency Medicine. https://doi.org/10.1111/acem.14803
Vancouver
Utsumi S, Amagasa S, Moriwaki T, Uematsu S. Oral analgesic for musculoskeletal injuries in children: A systematic review and network meta‐analysis. Academic Emergency Medicine. 2024. doi:10.1111/acem.14803
BibTeX
@article{Utsumi2024,
author = {Utsumi, Shu and Amagasa, Shunsuke and Moriwaki, Taro and Uematsu, Satoko},
title = {Oral analgesic for musculoskeletal injuries in children: A systematic review and network meta‐analysis},
journal = {Academic Emergency Medicine},
year = {2024},
doi = {10.1111/acem.14803}
}
EUVIMED